Sermorelin is a GHRH analog that supports the pituitary’s natural GH release pathway. It has decades of clinical use history and is the most commonly prescribed entry-tier GH-axis peptide.
2 minutes · No commitment · $249/mo if approved

Researching GH-axis support as part of a longevity protocol
Evaluating peptide therapy for the first time
Looking for an affordable entry to the GHRH analog class
Wanting a physician-supervised protocol with established safety data
Supports the pituitary’s natural pulsatile GH release pattern
Decades of clinical use history (originally FDA-approved as Geref)
Physician-supervised protocol with lab monitoring
Eligibility and dosing determined during intake, not before
Sermorelin
200-500mcg nightly, subcutaneous injection
A growth hormone releasing hormone (GHRH) analog that stimulates the body's own natural growth hormone production. Sermorelin was previously FDA-approved and has a long-established compounding pathway.
Flexible payment options available at checkout · Cancel anytime
Take a free 2-minute assessment. If a licensed provider approves your protocol, your medication ships directly to your door. Not approved? Your card is never charged.
Start Free AssessmentThese statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease. All prescription medications require a valid prescription from a licensed healthcare provider.